ClinicalTrials.Veeva

Menu

Biomarker Study for Prediction of aGVHD

S

Shanghai Jiao Tong University School of Medicine

Status

Unknown

Conditions

aGVHD

Study type

Observational

Funder types

Other

Identifiers

NCT03614143
SHTG-001

Details and patient eligibility

About

This is a prospective study in patients receiving allogeneic stem cell transplantation. The blood samples on Day-14, -7, 0 and every 7 days until D100 were collected together with clinical data. In the final analysis, cytokines and biomarkers analysis will be carried out and compared between patients in No aGVHD and grade II-IV aGVHD.

Full description

This is a prospective study, observation study in patients receiving allogeneic stem cell transplantation in 4 BMT centers in Shanghai. The blood samples (on Day-14, -7, 0 and every 7 days until D100) and clinical data will be collected. In the final analysis, a panel of cytokines and biomarkers analysis of serial blood samples will be carried out and compared between patients with no aGVHD and grade II-IV aGVHD.

Enrollment

250 estimated patients

Sex

All

Ages

16 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • all patients undergoing allogeneic stem cel transplantation
  • with informed consent
  • patients survived without aGVHD or relapse and patients with development of grade II-IV aGVHD

Exclusion criteria

  • patients with blood sample and clinical data not available

Trial contacts and locations

1

Loading...

Central trial contact

Jiong HU, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems